A significant shift is underway in the treatment of womb cancer as a new AI-powered blood test is set to revolutionize the process. Several NHS hospitals are preparing to use this innovative approach, which promises to help assess women referred for possible womb cancer before invasive checks are carried out.
According to The Guardian, around 90,000 postmenopausal women in England are referred by GPs each year for checks after experiencing heavy bleeding. Of these, approximately 10,000 are diagnosed with womb cancer annually. The current approach typically involves a combination of clinical examination, ultrasound, and other investigations, which can be time-consuming and costly.
The AI-powered blood test has the potential to greatly reduce the number of invasive womb cancer checks required, while also improving accuracy and reducing unnecessary procedures. By analyzing a patient's blood samples, doctors are able to identify early signs of cancer and recommend targeted treatment options, rather than proceeding with more invasive methods. As NHS hospitals begin to integrate this new technology into their protocols, patients can expect to undergo fewer tests and receive more personalized care in the process.